DOW
40
2
EW
51
-2
MSFT
46
-8
CL
56
2
EL
46
-2
UPS
37
5
BSX
52
-2
ADI
76
-2
NWSA
66
4
VRSK
21
-2
VNO
49
3
PPL
47
-5
APH
53
-5
AES
57
2
LYB
13
2
OKE
58
2
DVN
44
-3
DIS
62
-2
ETR
52
-2
HRL
36
-2
DOW
40
2
EW
51
-2
MSFT
46
-8
CL
56
2
EL
46
-2
UPS
37
5
BSX
52
-2
ADI
76
-2
NWSA
66
4
VRSK
21
-2
VNO
49
3
PPL
47
-5
APH
53
-5
AES
57
2
LYB
13
2
OKE
58
2
DVN
44
-3
DIS
62
-2
ETR
52
-2
HRL
36
-2
Financhill
Back

Gitlab, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
21

GTLB
Gitlab, Inc.

Last Price:
$40.47
Seasonality Move:
4.37%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
21
Gitlab, Inc. (GTLB) is a Sell

Is Gitlab, Inc. a Buy, Sell or Hold?

  • The current Gitlab, Inc. [GTLB] share price is $39.02. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

GTLB Stock Price Chart

What is Gitlab, Inc.'s stock price today?

  • The Gitlab, Inc. share price today is $39.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.98 Sell
Relative Strength Index (14 RSI): 38.7 Sell
Chaikin Money Flow: 158844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.69 - 45.49) Sell
Bollinger Bands (100): (42.2 - 48.6) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.55 Sell
20-day SMA: 41.76 Sell
50-day SMA: 44.78 Sell
200-day SMA: 46.55 Sell
8-day EMA: 39.43 Sell
20-day EMA: 41.4 Sell
50-day EMA: 43.78 Sell
200-day EMA: 47.35 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Gitlab, Inc. Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Gitlab, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):